Gabor M. Rubanyi
Geen lopende functies
Profiel
Gabor M.
Rubanyi is the founder of NanoCor Therapeutics, Inc. founded in 2005.
He worked as a Director of Vascular & Endothelial Research at Berlex, Inc. from 1992 to 1999 and as a Director of Pharmacology Institute at Bayer Schering Pharma AG from 1990 to 1992.
He also served as a Director at Hybrid BioSystems Ltd.
and Hybrid Systems Ltd.
He was the Pharmacology Director at Berlex Laboratories, Inc. from 1987 to 1990.
He worked as the Chief Scientific Officer at Taxus Cardium Pharmaceuticals Group, Inc. and as the Vice President of Gene Therapy at Berlex Biosciences.
He was an Associate Professor at Mayo Medical School from 1983 to 1987.
Eerdere bekende functies van Gabor M. Rubanyi
| Bedrijven | Functie | Einde |
|---|---|---|
Berlex, Inc.
 Berlex, Inc. Pharmaceuticals: MajorHealth Technology Berlex, Inc. manufactured pharmaceutical company. It developed novel diagnostics and therapeutics, which address unmet medical needs. It used to researches, develops, manufactures and markets ethical pharmaceuticals in five strategic areas such as female healthcare, diagnostic imaging, dermatology, oncology and therapeutics. The company was headquartered in Wayne, NJ | Corporate Officer/Principal | 01-01-1999 |
| Bayer Schering Pharma AG | Corporate Officer/Principal | 01-01-1992 |
| Berlex Laboratories, Inc. | Corporate Officer/Principal | 01-01-1990 |
| Mayo Medical School | Corporate Officer/Principal | 01-01-1987 |
| Hybrid Systems Ltd. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GENE BIOTHERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 7 |
|---|---|
Berlex, Inc.
Berlex, Inc. Pharmaceuticals: MajorHealth Technology Berlex, Inc. manufactured pharmaceutical company. It developed novel diagnostics and therapeutics, which address unmet medical needs. It used to researches, develops, manufactures and markets ethical pharmaceuticals in five strategic areas such as female healthcare, diagnostic imaging, dermatology, oncology and therapeutics. The company was headquartered in Wayne, NJ | Health Technology |
| Bayer Schering Pharma AG | Health Technology |
NanoCor Therapeutics, Inc.
 NanoCor Therapeutics, Inc. BiotechnologyHealth Technology NanoCor Therapeutics, Inc. provides biotechnology products and services. It focuses on treating cardiovascular disease at the molecular level. The company was founded by Roger A. Hajjar, Sheila A. Mikhail, and Gabor M. Rubanyi in 2005 and is headquartered in Chapel Hill, NC. | Health Technology |
Hybrid BioSystems Ltd.
 Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Hybrid is an Oxford Biotechnology Company focused on revolutionizing viral vaccines with its patented vaccine delivery technologies. Hybrid has an established and well equipped laboratory located at Cherwell Innovation Centre in Oxford shire, which houses both its corporate research facility and contract research services. Using a mixed product and platform business model it is developing its in-house lead products towards phase I/II proof of concept clinical trials as well as furthering its partnerships with leading pharmaceutical and biotechnology companies. Hybrid's experienced scientific and management team has reached this late stage of development through a highly efficient use of grant funding and revenues, together with minimal seed funding. With its unparalleled expertise in the field of viral steal thing technologies, The firm is also able to offer general and bespoke virology services, including high-quality adenovirus production and purification. Hybrid BioSystems uses iLabber electronic lab books for maximum IP protection and secure data storage. | Commercial Services |
| Berlex Biosciences | |
| Berlex Laboratories, Inc. | |
| Hybrid Systems Ltd. |